Beneficial effects of adenosine A2a agonist CGS-21680 in infarcted and stunned porcine myocardium

American Journal of Physiology - Heart and Circulatory Physiology

Volumn 280, Issue 4 49-4, 2001, Pages

  Lasley, Robert D ^a,b   Jahania, M Salik ^a   Mentzer Jr , Robert M ^a  

^a UNIVERSITY OF KENTUCKY   (United States)

^b UNIVERSITY OF KENTUCKY MEDICAL CENTER   (United States)

Author keywords

Adenosine A2a receptor; Myocardial infarction; Myocardial stunning; Preload recruitable stroke work

Indexed keywords

2 [4 (2 CARBOXYETHYL)PHENETHYLAMINO]ADENOSINE 5' (N ETHYLCARBOXAMIDE); ADENOSINE A2A RECEPTOR AGONIST; CYCLIC AMP;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG ACTIVITY; DRUG EFFECT; HEART CONTRACTION; HEART INFARCTION; HEART MUSCLE REPERFUSION; HEART PRELOAD; HEMODYNAMICS; INOTROPISM; NONHUMAN; PRIORITY JOURNAL; STUNNED HEART MUSCLE; SWINE;

EID: 0035008669     PISSN: 03636135     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpheart.2001.280.4.h1660     Document Type: Article

References (38)

1. Abebe W, Hussain T, Olanrewaju H, and Mustafa SJ. Role of nitric oxide in adenosine receptor-mediated relaxation of porcine coronary artery. Am J Physiol Heart Circ Physiol 269: H1672-H1678, 1995.
2. 6-(3-iodobenzyl)adenosine-5′-N-methyluronamide protects against myocardial stunning and infarction without hemodynamic changes in conscious rabbits. Circ Res 80: 800-809, 1997.
3. 2-adenosine receptor agonist, in the mammalian ventricle. J Cardiovasc Pharmacol 30: 750-758, 1997.
4. Buxton IL and Brunton LL. Compartments of cyclic AMP and protein kinase in mammalian cardiomyocytes. J Biol Chem 258: 10233-10239, 1983.
5. 2 receptor function in rat ventricular myocytes. Cardiovasc Res 34: 337-347, 1997.
6. Caldarone CA, Krukenkamp IB, Burns PG, Misare BD, Gaudette GR, and Levitsky S. Ischemia-dependent efficacy of phosphodiesterase inhibition. Ann Thorac Surg 57: 540-545, 1994.
7. Gao F, Christopher TA, Lopez BL, Friedman E, Cai G, and Ma XL. Mechanism of decreased adenosine protection in reperfusion injury of aging rats. Am J Physiol Heart Circ Physiol 279: H329-H338, 2000.
8. Glower DD, Spratt JA, Snow ND, Kabas JS, and Davis Rankin JS. Linearity of the Frank-Starling relationship in the intact heart: the concept of preload recruitable stroke work. Circulation 71: 994-1009, 1985.
9. Goto M, Miura T, Iliodoromitis EK, O'Leary EL, Ishimoto R, Yellon DM, and Iimura O. Adenosine infusion during early reperfusion failed to limit myocardial infarct size in a collateral deficient species. Cardiovasc Res 25: 943-949, 1991.
10. Hein TW and Kuo L. cAMP-independent dilation of coronary arterioles to adenosine: role of nitric oxide, G proteins, and K(ATP) channels. Circ Res 85: 634-642, 1999.
11. Hohl CM and Li QA. Compartmentation of cAMP in adult canine ventricular myocytes. Relation to single-cell free Ca2+ transients. Circ Res 69: 1369-1379, 1991.
12. Homeister JW, Hoff PT, Fletcher DD, and Lucchesi BR. Combined adenosine and lidocaine administration limits myocardial reperfusion injury. Circulation 82: 595-608, 1990.
13. Jahania MS, Lasley RD, and Mentzer RM Jr. Ischemic preconditioning does not acutely improve load-insensitive parameters of contractility in in vivo stunned porcine myocardium. J Thorac Cardiovasc Surg 117: 810-817, 1999.
14. Jordan JE, Zhao ZQ, Sato H, Taft S, and Vinten-Johansen J. Adenosine A2 receptor activation attenuates reperfusion injury by inhibiting neutrophil accumulation, superoxide generation and coronary endothelial adherence. J Pharmacol Exp Ther 280: 301-309, 1997.
15. Lasley RD. The protective effects of adenosine in reversibly and irreversibly injured ischemic myocardium. In: Effects of Extracellular Adenosine and ATP on Cardiomyocytes, edited by Pelleg A and Belardinelli L. Austin, TX: Landes, 1998, p. 133-172.
16. 1 receptor mechanism. Am J Physiol Heart Circ Physiol 263: H1460-H1465, 1992.
17. Luss H, Meissner A, Rolf N, Van Aken H, Boknik P, Kirchhefer U, Knapp J, Laer S, Linck B, Luss I, Muller FU, Neumann J, and Schmitz W. Biochemical mechanism(s) of stunning in conscious dogs. Am J Physiol Heart Circ Physiol 279: H176-H184, 2000.
18. 2A receptors in human and porcine cardiovascular tissues. J Pharmacol Exp Ther 286: 1061-1057, 1998.
19. 1 adenosine receptors of intact rat ventricular myocytes. Circ Res 63: 613-620, 1988.
20. Mohan P, Brutsaert DL, Paulus WJ, and Sys SU. Myocardial contractile response to nitric oxide and cGMP. Circulation 93: 1223-1229, 1996.
21. 2-receptor agonists on myocardial reperfusion injury. Am Heart J 123: 332-338, 1992.
22. Norton ED, Jackson EK, Virmani R, and Forman MB. Effect of intravenous adenosine on myocardial reperfusion injury in a model with low myocardial collateral blood flow. Am Heart J 122: 1283-1291, 1991.
23. Olafsson B, Forman MB, Puett DW, Pou A, Cates CU, Friesinger GC, and Virmani R. Reduction of reperfusion injury in the canine preparation by intracoronary adenosine: importance of the endothelium and the no-reflow phenomenon. Circulation 76: 1135-1145, 1987.
24. Pitarys CJ, Virmani R, Vildibill HD Jr, Jackson EK, and Forman MB. Reduction of myocardial reperfusion injury by intravenous adenosine administered during the early reperfusion period. Circulation 83: 237-247, 1991.
25. Randhawa MPS Jr, Lasley RD, and Mentzer RM Jr. Salutary effects of exogenous adenosine on canine myocardial stunning in vivo. J Thorac Cardiovasc Surg 110: 63-74, 1995.
26. 2-receptor activation at reperfusion reduces infarct size and improves myocardial wall function in dog heart. J Cardiovasc Pharmacol 22: 89-96, 1993.
27. Schulze W, Wolf WP, Fu ML, Morwinski R, Buchwalow IB, and Will-Shahab L. Immunocytochemical studies of the Gi protein mediated muscarinic receptor-adenylyl cyclase system. Mol Cell Biochem 147: 161-168, 1995.
28. Sekili S, Jeroudi MO, Tang XL, Zughaib M, Sun JZ, and Bolli R. Effect of adenosine on myocardial 'stunning' in the dog. Circ Res 76: 82-94, 1995.
29. 2A-adenosine receptor reserve for coronary vasodilation. Circulation 98: 711-718, 1998.
30. Stahl LD, Aversano TR, and Becker LC. Selective enhancement of function of stunned myocardium by increased flow. Circulation 74: 843-851, 1986.
31. 2-adenosine receptors in guinea-pig ventricular cardiomyocytes. J Mol Cell Cardiol 26: 403-414, 1994.
32. ATP channels. Am J Physiol Heart Circ Physiol 277: H228-H235, 1999.
33. Vanden Hoek TL, Becker LB, Shao Z-H, Li C-Q, and Schumacker PT. Preconditioning in cardiomyocytes protects by attenuating oxidant stress at reperfusion. Circ. Res 86: 541-548, 2000.
34. Vander Heide RS and Reimer KA. Effect of adenosine therapy at reperfusion on myocardial infarct size in dogs. Cardiovasc Res 31: 711-718, 1996.
35. Vila-Petroff MG, Younes A, Egan J, Lakatta EG, and Sollott SJ. Activation of distinct cAMP-dependent and cGMP-dependent pathways by nitric oxide in cardiac myocytes. Circ Res 84: 1020-1031, 1999.
36. Weyrich AS, Ma XL, Buerke M, Murohara T, Armstead VE, Lefer AM, Nicolas JM, Thomas AP, Lefer DJ, and Vinten-Johansen J. Physiological concentrations of nitric oxide do not elicit an acute negative inotropic effect in unstimulated cardiac muscle. Circ Res 75: 692-700, 1994.
37. 2a receptor in adult rat ventricular myocyte Am J Physiol Heart Circ Physiol 270: H1655-H1661, 1996.
38. 2-receptor activation inhibits neutrophil-mediated injury to coronary endothelium. Am J Physiol Heart Circ Physiol 271: H1456-H1464, 1996.